Direct delivery of anticancer agents: Experimental treatment of intraocular malignancy

H. S. Liu, M. F. Refojo, H. D. Perry, Daniel Albert

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Two anticancer agents, one lipophilic, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), and one hydrophilic, 5-(3,3-dimethyl-1-triazeno) imidazol-4-carboxamide (DTIC), were used to treat Brown-Pearce epithelioma in the anterior chamber of rabbit eyes. The BCNU test animals were divided into three groups: one treated by direct injection of the drug into the subconjunctival space or the anterior chamber, the second by both direct injection and intravenous administration, and the third by intravenous injection alone. The DTIC test animals were treated with only local injection into the subconjunctival space or anterior chamber. Dosage, delivery system, and effectiveness were compared following clinical observation and histopathologic examination. Direct delivery of BCNU or DTIC in subconjunctival space or anterior chamber delayed the growth of Brown-Pearce epithelioma in rabbit eye. The effectiveness of this treatment was significantly enhanced by combining direct injection with systemic administration of a lower dose of BCNU.

Original languageEnglish (US)
Pages (from-to)993-1004
Number of pages12
JournalInvestigative Ophthalmology and Visual Science
Volume17
Issue number10
StatePublished - Jan 1 1978
Externally publishedYes

Fingerprint

Carmustine
Antineoplastic Agents
Anterior Chamber
Brown-Pearce Carcinoma
Injections
Neoplasms
Rabbits
Therapeutics
Dacarbazine
Intravenous Injections
Intravenous Administration
Observation
Growth
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Direct delivery of anticancer agents : Experimental treatment of intraocular malignancy. / Liu, H. S.; Refojo, M. F.; Perry, H. D.; Albert, Daniel.

In: Investigative Ophthalmology and Visual Science, Vol. 17, No. 10, 01.01.1978, p. 993-1004.

Research output: Contribution to journalArticle

@article{3def68b461bd4a769d8a98ac12b4661f,
title = "Direct delivery of anticancer agents: Experimental treatment of intraocular malignancy",
abstract = "Two anticancer agents, one lipophilic, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), and one hydrophilic, 5-(3,3-dimethyl-1-triazeno) imidazol-4-carboxamide (DTIC), were used to treat Brown-Pearce epithelioma in the anterior chamber of rabbit eyes. The BCNU test animals were divided into three groups: one treated by direct injection of the drug into the subconjunctival space or the anterior chamber, the second by both direct injection and intravenous administration, and the third by intravenous injection alone. The DTIC test animals were treated with only local injection into the subconjunctival space or anterior chamber. Dosage, delivery system, and effectiveness were compared following clinical observation and histopathologic examination. Direct delivery of BCNU or DTIC in subconjunctival space or anterior chamber delayed the growth of Brown-Pearce epithelioma in rabbit eye. The effectiveness of this treatment was significantly enhanced by combining direct injection with systemic administration of a lower dose of BCNU.",
author = "Liu, {H. S.} and Refojo, {M. F.} and Perry, {H. D.} and Daniel Albert",
year = "1978",
month = "1",
day = "1",
language = "English (US)",
volume = "17",
pages = "993--1004",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "10",

}

TY - JOUR

T1 - Direct delivery of anticancer agents

T2 - Experimental treatment of intraocular malignancy

AU - Liu, H. S.

AU - Refojo, M. F.

AU - Perry, H. D.

AU - Albert, Daniel

PY - 1978/1/1

Y1 - 1978/1/1

N2 - Two anticancer agents, one lipophilic, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), and one hydrophilic, 5-(3,3-dimethyl-1-triazeno) imidazol-4-carboxamide (DTIC), were used to treat Brown-Pearce epithelioma in the anterior chamber of rabbit eyes. The BCNU test animals were divided into three groups: one treated by direct injection of the drug into the subconjunctival space or the anterior chamber, the second by both direct injection and intravenous administration, and the third by intravenous injection alone. The DTIC test animals were treated with only local injection into the subconjunctival space or anterior chamber. Dosage, delivery system, and effectiveness were compared following clinical observation and histopathologic examination. Direct delivery of BCNU or DTIC in subconjunctival space or anterior chamber delayed the growth of Brown-Pearce epithelioma in rabbit eye. The effectiveness of this treatment was significantly enhanced by combining direct injection with systemic administration of a lower dose of BCNU.

AB - Two anticancer agents, one lipophilic, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), and one hydrophilic, 5-(3,3-dimethyl-1-triazeno) imidazol-4-carboxamide (DTIC), were used to treat Brown-Pearce epithelioma in the anterior chamber of rabbit eyes. The BCNU test animals were divided into three groups: one treated by direct injection of the drug into the subconjunctival space or the anterior chamber, the second by both direct injection and intravenous administration, and the third by intravenous injection alone. The DTIC test animals were treated with only local injection into the subconjunctival space or anterior chamber. Dosage, delivery system, and effectiveness were compared following clinical observation and histopathologic examination. Direct delivery of BCNU or DTIC in subconjunctival space or anterior chamber delayed the growth of Brown-Pearce epithelioma in rabbit eye. The effectiveness of this treatment was significantly enhanced by combining direct injection with systemic administration of a lower dose of BCNU.

UR - http://www.scopus.com/inward/record.url?scp=0017846756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017846756&partnerID=8YFLogxK

M3 - Article

C2 - 700954

AN - SCOPUS:0017846756

VL - 17

SP - 993

EP - 1004

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 10

ER -